Carrie Dougherty is a Neurology physician affiliated with Georgetown University. OpenAlex indexes 39 publications with 364 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
21 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
98.5%Neuromuscular Blocker98.5%Onabotulinumtoxina100%Botox0%Part D + Part B<11 patientsNervous system
1.4%Calcitonin gene-related peptide (CGRP) antagonists0.5%Ajovy Autoinjector34%Aimovig Autoinjector33%Emgality Pen20%Ajovy Syringe14%Part D<11 patientsCalcitonin Gene-related Peptide Receptor Antagonist0.3%Ubrelvy61%Nurtec Odt39%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
0.1%Serotonin-3 Receptor Antagonist0.1%Ondansetron Odt100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The 2025 Scottsdale Headache Symposium: New beginnings
Headache The Journal of Head and Face Pain
2025 - 434 The Safety and Efficacy of Intranasal Fentanyl and Midazolam for Pediatric Anxiolysis
Annals of Emergency Medicine
2024 - Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long‐term clinical trial data
Headache The Journal of Head and Face Pain
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Augusto Pichard, MD
Georgetown University
Virginia Steen
Georgetown University
Joseph Verbalis
Georgetown University
Craig Kessler
Georgetown University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”